Titre : Protéines angiostatiques

Protéines angiostatiques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Sensitivity and Specificity
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines angiostatiques : Questions médicales les plus fréquentes", "headline": "Protéines angiostatiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines angiostatiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-11", "dateModified": "2025-05-06", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines angiostatiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines angiogéniques", "url": "https://questionsmedicales.fr/mesh/D042501", "about": { "@type": "MedicalCondition", "name": "Protéines angiogéniques", "code": { "@type": "MedicalCode", "code": "D042501", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.100" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Angiostatines", "alternateName": "Angiostatins", "url": "https://questionsmedicales.fr/mesh/D043168", "about": { "@type": "MedicalCondition", "name": "Angiostatines", "code": { "@type": "MedicalCode", "code": "D043168", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.100.450.500" } } }, { "@type": "MedicalWebPage", "name": "Endostatines", "alternateName": "Endostatins", "url": "https://questionsmedicales.fr/mesh/D043169", "about": { "@type": "MedicalCondition", "name": "Endostatines", "code": { "@type": "MedicalCode", "code": "D043169", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.100.450.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Protéines angiostatiques", "alternateName": "Angiostatic Proteins", "code": { "@type": "MedicalCode", "code": "D043165", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Carolyn G Chen", "url": "https://questionsmedicales.fr/author/Carolyn%20G%20Chen", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Anatomy, and Cell Biology and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107." } }, { "@type": "Person", "name": "Renato V Iozzo", "url": "https://questionsmedicales.fr/author/Renato%20V%20Iozzo", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Anatomy, and Cell Biology and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 renato.iozzo@jefferson.edu." } }, { "@type": "Person", "name": "Catherine E Simpson", "url": "https://questionsmedicales.fr/author/Catherine%20E%20Simpson", "affiliation": { "@type": "Organization", "name": "Dept of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA." } }, { "@type": "Person", "name": "Megan Griffiths", "url": "https://questionsmedicales.fr/author/Megan%20Griffiths", "affiliation": { "@type": "Organization", "name": "Dept of Pediatrics, Division of Pediatric Cardiology, Johns Hopkins University, Baltimore, MD, USA." } }, { "@type": "Person", "name": "Jun Yang", "url": "https://questionsmedicales.fr/author/Jun%20Yang", "affiliation": { "@type": "Organization", "name": "Dept of Pediatrics, Division of Pediatric Cardiology, Johns Hopkins University, Baltimore, MD, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Cut-off point, sensitivity and specificity for screening the reading fluency in children.", "datePublished": "2023-06-02", "url": "https://questionsmedicales.fr/article/37283398", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/2317-1782/20232021263pt" } }, { "@type": "ScholarlyArticle", "name": "Sensitivity and Specificity of Wearables for Atrial Fibrillation in Elderly Populations: A Systematic Review.", "datePublished": "2023-05-24", "url": "https://questionsmedicales.fr/article/37222916", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11886-023-01898-3" } }, { "@type": "ScholarlyArticle", "name": "Sensitivity and specificity of three screening tools for frailty in hospitalized older adults.", "datePublished": "2023-01-05", "url": "https://questionsmedicales.fr/article/36640700", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijnurstu.2022.104435" } }, { "@type": "ScholarlyArticle", "name": "Sensitivity and specificity of diagnostic modalities in pouchitis: a systematic review and meta-analysis.", "datePublished": "2023-09-11", "url": "https://questionsmedicales.fr/article/37695613", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MEG.0000000000002638" } }, { "@type": "ScholarlyArticle", "name": "Combination of ST2 With Organ-Specific Biomarker is More Sensitive and Specific for the Diagnosis of Acute Graft-vs-Host Disease.", "datePublished": "2023-06-27", "url": "https://questionsmedicales.fr/article/37385841", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.transproceed.2023.04.043" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Protéines et peptides de signalisation intercellulaire", "item": "https://questionsmedicales.fr/mesh/D036341" }, { "@type": "ListItem", "position": 4, "name": "Protéines angiogéniques", "item": "https://questionsmedicales.fr/mesh/D042501" }, { "@type": "ListItem", "position": 5, "name": "Protéines angiostatiques", "item": "https://questionsmedicales.fr/mesh/D043165" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines angiostatiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines angiostatiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Protéines angiostatiques", "description": "Comment diagnostiquer une dysrégulation angiostatique ?\nQuels examens sont utilisés pour évaluer les protéines angiostatiques ?\nLes imageries médicales aident-elles au diagnostic ?\nQuels marqueurs biologiques sont associés aux protéines angiostatiques ?\nPeut-on détecter les protéines angiostatiques dans le sang ?", "url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Sensitivity+and+Specificity&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Protéines angiostatiques", "description": "Quels symptômes indiquent une dysfonction angiostatique ?\nLes troubles de la vision sont-ils liés aux protéines angiostatiques ?\nComment les protéines angiostatiques affectent-elles la peau ?\nY a-t-il des symptômes systémiques associés ?\nLes douleurs articulaires peuvent-elles être liées ?", "url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Sensitivity+and+Specificity&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Protéines angiostatiques", "description": "Comment prévenir les troubles liés aux protéines angiostatiques ?\nL'exercice physique aide-t-il à prévenir ces troubles ?\nY a-t-il des aliments à privilégier ?\nLe tabagisme influence-t-il la santé angiostatique ?\nLe stress a-t-il un impact sur l'angiogenèse ?", "url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Sensitivity+and+Specificity&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Protéines angiostatiques", "description": "Quels traitements ciblent les protéines angiostatiques ?\nLes traitements sont-ils efficaces contre le cancer ?\nY a-t-il des effets secondaires aux traitements ?\nLes traitements sont-ils personnalisés ?\nDes thérapies complémentaires sont-elles recommandées ?", "url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Sensitivity+and+Specificity&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Protéines angiostatiques", "description": "Quelles complications peuvent survenir avec une dysrégulation ?\nLes maladies cardiovasculaires sont-elles liées ?\nY a-t-il un lien avec les maladies rénales ?\nLes complications neurologiques sont-elles possibles ?\nComment les complications affectent-elles la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Sensitivity+and+Specificity&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Protéines angiostatiques", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe diabète est-il un facteur de risque ?\nLe mode de vie sédentaire est-il un risque ?", "url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Sensitivity+and+Specificity&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysrégulation angiostatique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des biopsies peuvent aider à évaluer l'angiogenèse." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer les protéines angiostatiques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'immunohistochimie et les dosages ELISA sont couramment utilisés." } }, { "@type": "Question", "name": "Les imageries médicales aident-elles au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'IRM et l'échographie peuvent visualiser les anomalies vasculaires." } }, { "@type": "Question", "name": "Quels marqueurs biologiques sont associés aux protéines angiostatiques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme le VEGF et l'angiostatine sont souvent mesurés." } }, { "@type": "Question", "name": "Peut-on détecter les protéines angiostatiques dans le sang ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines protéines peuvent être quantifiées dans le sérum." } }, { "@type": "Question", "name": "Quels symptômes indiquent une dysfonction angiostatique ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des douleurs, des œdèmes ou des troubles de la circulation peuvent apparaître." } }, { "@type": "Question", "name": "Les troubles de la vision sont-ils liés aux protéines angiostatiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une angiogenèse anormale peut causer des troubles visuels." } }, { "@type": "Question", "name": "Comment les protéines angiostatiques affectent-elles la peau ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent provoquer des lésions cutanées dues à une circulation sanguine altérée." } }, { "@type": "Question", "name": "Y a-t-il des symptômes systémiques associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fatigue ou la fièvre peuvent survenir dans certains cas." } }, { "@type": "Question", "name": "Les douleurs articulaires peuvent-elles être liées ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une mauvaise circulation peut entraîner des douleurs articulaires." } }, { "@type": "Question", "name": "Comment prévenir les troubles liés aux protéines angiostatiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée, est recommandé." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il à prévenir ces troubles ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier améliore la circulation sanguine et la santé vasculaire." } }, { "@type": "Question", "name": "Y a-t-il des aliments à privilégier ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des aliments riches en antioxydants, comme les fruits et légumes, sont bénéfiques." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il la santé angiostatique ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme nuit à la circulation et favorise les troubles angiostatiques." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur l'angiogenèse ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut perturber l'équilibre angiostatique." } }, { "@type": "Question", "name": "Quels traitements ciblent les protéines angiostatiques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et des médicaments anti-angiogéniques sont utilisés." } }, { "@type": "Question", "name": "Les traitements sont-ils efficaces contre le cancer ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les inhibiteurs de l'angiogenèse sont utilisés dans certains cancers." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets comme l'hypertension ou des saignements peuvent survenir." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être adaptés selon le type de cancer et le patient." } }, { "@type": "Question", "name": "Des thérapies complémentaires sont-elles recommandées ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des approches comme l'acupuncture peuvent être envisagées en complément." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une dysrégulation ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des thromboses ou des hémorragies peuvent se produire." } }, { "@type": "Question", "name": "Les maladies cardiovasculaires sont-elles liées ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une mauvaise régulation angiostatique peut augmenter le risque cardiovasculaire." } }, { "@type": "Question", "name": "Y a-t-il un lien avec les maladies rénales ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles angiostatiques peuvent affecter la fonction rénale." } }, { "@type": "Question", "name": "Les complications neurologiques sont-elles possibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de la circulation peuvent entraîner des complications neurologiques." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent réduire la qualité de vie en limitant les activités quotidiennes." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'obésité, le tabagisme et l'hypertension sont des facteurs de risque majeurs." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge en raison de la dégradation vasculaire." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies vasculaires augmentent le risque." } }, { "@type": "Question", "name": "Le diabète est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète peut altérer la régulation angiostatique et augmenter les complications." } }, { "@type": "Question", "name": "Le mode de vie sédentaire est-il un risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire contribue à une mauvaise santé vasculaire." } } ] } ] }

Sources (10000 au total)

Cut-off point, sensitivity and specificity for screening the reading fluency in children.

to establish cut-off point for reading speed and accuracy, to obtain minimum values for comprehending texts, and allow classifying students from 2nd to 5th grade of elementary school according to good... 147 assessment protocols for oral reading and text comprehension of students from 3rd to 5th grade of Elementary School with and without reading difficulties were analyzed. The oral text reading rate ... Sensitivity and specificity for measures of rate and accuracy in text reading were calculated for the 3rd, 4th, and 5th grades. Rate and precision under the ROC curve did not differ statistically. The... The cutoff values expected for students from 2nd to 3rd grade were identified, with recommendations for using the oral text reading rate for reading comprehension screening procedures....

Sensitivity and Specificity of Wearables for Atrial Fibrillation in Elderly Populations: A Systematic Review.

This study aims to evaluate the sensitivity and specificity of wearable devices for AF detection in older adults, as well as examine the incidence of AF across various studies, contextual factors impa... A systematic search of three databases identified 30 studies on wearables for AF detection in older adults, encompassing 111,798 participants. Both PPG-based and single-lead electrocardiography-based ...

Sensitivity and specificity of three screening tools for frailty in hospitalized older adults.

To determine the test accuracy, including sensitivity, specificity, positive predictive value, negative predictive value and area under curve, of three frailty screening tools in identifying the risk ... Prospective longitudinal study.... The screening tools [Frail-PPS (Frail-Physical, Psychological and Social), Frailty Assessment Measure (FAM), and Identification of seniors at-risk hospitalized patients (ISAR-HP)] were administered by... Of 366 patients enrolled in the study, 78 (21.3%) experienced one or more frail outcomes, with 65 (17.76%) experiencing functional decline, 61 (16.67%) requiring a full-time caregiver upon discharge a... With high specificity and negative predictive values, as well as low sensitivity, FAM and Frail-PPS may be beneficial in identifying older individuals who are not frail, minimizing unnecessary further...

Combination of ST2 With Organ-Specific Biomarker is More Sensitive and Specific for the Diagnosis of Acute Graft-vs-Host Disease.

Diagnosis of acute graft-vs-host disease (aGVHD) based on clinical symptoms and biopsy of involved organ was not satisfactory; reliable plasma biomarkers or their panels would be of great value to inc... One hundred two patients who received allogeneic hematopoietic stem cell transplantation in our center were included in this study. Systemic biomarkers of ST2, IP10, IL-2Rα, TNFR1, and organ-specific ... The level of each systemic biomarker in aGVHD patients was significantly higher than that in patients without aGVHD. Organ-specific biomarker of Elafin, REG-3α, and KRT-18F also had predictive value f... All the biomarkers tested in our study correlated with the severity and clinical course of aGVHD. Combination of each systemic biomarker with organ-specific biomarker could increase the sensitivity an...

ERA-CRISPR/Cas12a system: a rapid, highly sensitive and specific assay for

The CRISPR/Cas system, commonly known as the "gene scissors", demonstrates remarkable specificity and efficient signal amplification capabilities. Enzymatic recombinase amplification (ERA) was utilize... The sensitivity of the ERA-CRISPR/Cas12a fluorescence and lateral flow systems was 9 copies/μL and 90 copies/μL, respectively. Simultaneously, the detection system exhibited no cross-reactivity with v... The ERA-CRISPR/Cas12a system offers a rapid, sensitive, and specific method that presents a novel approach to laboratory diagnosis of...

Sensitivity and specificity of secondary dose calculation for head and neck treatment plans.

Secondary dose calculation (SDC) with an independent algorithm is one option to perform plan-specific quality assurance (QA). While measurement-based QA can potentially detect errors in plan delivery,... Thirty head and neck VMAT plans and 30 modifications of those plans, including errors related to density and beam modelling, were recalculated using RadCalc with a Monte Carlo algorithm. Decision thre... Despite optimized decision thresholds, none of the systems was able to reliably detect all errors. ArcCHECK analysis using a 2%/2 mm criterion with a threshold of 91.1% had an area under the curve (AU... Secondary dose calculation with RadCalc is an alternative to established measurement-based phantom QA. Different tools catch different errors; therefore, a combination of approaches should be preferre...